Profile
AGRX TAK ZTS HLN TEVA VTRS
Company Name Agile Therapeutics, Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $10.43M $57.18B $56.15B $49.48B $39.42B $14.94B
Employees 0.02K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Alfred F. Altomari Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
AGRX TAK ZTS HLN TEVA VTRS
Quant Rating Score 2 3 3 4 3 2
Quant Rating Sell Neutral Neutral Buy Neutral Sell
Trading
AGRX TAK ZTS HLN TEVA VTRS
Last Close $1.51 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $1.51 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $1.51 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High 0 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 0 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
AGRX TAK ZTS HLN TEVA VTRS
1 Month Return 0 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return 0 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 0 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 0 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 0 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 0 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AGRX TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.55 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) - 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
AGRX TAK ZTS HLN TEVA VTRS
Asset Growth -27.99 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth 162.23 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth 80.02 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year -48.64 % 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year - 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year - 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth 51.6 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth 43.08 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share 99.48 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share 99.42 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share 99.79 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth 52.01 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) 73.36 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG 99.6 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG 99.55 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG 99.85 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth 88.59 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth 88.59 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share 41.02 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share -100.65 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share -100.64 % 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share 99.95 % 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share - 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share - 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth -1.76 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth 73.46 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
AGRX TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 54.18 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -141.05 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM 132.32 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM 188.98 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 100 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 72.75 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -101.49 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -440.93 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 5.78 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 0.94 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 3.28 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 4023.2 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 191.06 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -4.44 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -4.44 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 118.56 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -48.88 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -440.93 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -1.09 9.47 25.07 38.08 26.39 9.34
Price To Operating Cash Flows Ratio TTM -0.34 7.85 19.35 35.1 19.83 7.62
Price Cash Flow Ratio TTM -0.34 7.85 19.35 35.1 19.83 7.62
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.44
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AKAN Akanda Corp. 0.95
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.85
ALVOW Alvotech 0.4118
AMPH Amphastar Pharmaceuticals, Inc. 28.59
AMRX Amneal Pharmaceuticals, Inc. 14.7
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 76.25
APUS Apimeds Pharmaceuticals US, Inc 1.45
AQST Aquestive Therapeutics, Inc. 3.82
ASRT Assertio Holdings, Inc. 11.95
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
AYTU Aytu BioPharma, Inc. 2.27
ETFs With Exposure to AGRX
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.38
VXF Vanguard Extended Market Index Fund 0 218.1
VQNPX Vanguard Growth and Income Fund 0 67.82
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 110.66
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.55
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.56
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
VEMPX Vanguard Extended Market Index InstlPlus 0 408.54
Unlock